Content 2000


Butenko Z.A., Zavelevich M.P., Smirnova I.A., Khaetsky I.K., Phylchenkov A.A., Kishinskaya E.G., Baranovskaya L.N.
DIFFERENT ETOPOSIDE-INDUCED APOPTOTIC RESPONSE OF HUMAN MALIGNANT LYMPHOID CELL LINES
Vol. 22     N1-2. - C.26.

Hiyama T., Haruma K., Kitadai Y., Tanaka S., Yoshihara M., Sumii K., Shimamoto F., Kajiyama1 G.
ERADICATION THERAPY OF HELICOBACTER PYLORI FOR LOW-GRADE MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMAS OF THE STOMACH
Vol. 22     N1-2. - C.78.

Saito T., Seo S., Tanosaki R., Takaue Y., Mineishi S.
NON-MYELOABLATIVE STEM CELL TRANSPLANT USING 2-CHLORODEOXYADENOSINE (2-CdA) IN A PATIENT WITH MYELODYSPLASTIC SYNDROME (MDS)
Vol. 22     N1-2. - C.88.

Gluzman D.F., Abramenko I.V., Machilo V.M.
LARGE GRANULAR LYMPHOCYTE LEUKEMIA IN CHERNOBYL CLEAN-UP WORKERS
Vol. 22     N1-2. - C.84.

Imamura N.
HIGH INCIDENCE OF NEUTROPENIA CAUSED BY NK OR NK LIKE T-CELL PROLIFERATIVE DISORDERS AMONG ATOMIC BOMB SURVIVORS
Vol. 22     N1-2. - C.82.

Imamura N.
ANNOTATION. NEW TREATMENT STRATEGY FOR MALIGNANT HEMATOLOGIC DISORDERS AND NEOPLASIA BY GRAFT VERSUS LEUKEMIA/TUMOR REACTION
Vol. 22     N1-2. - C.86.

Oguma N., Hyodo H., Tanaka H., Kimura A.
VARIOUS RESPONSE PATTERNS OF Ph' CELLS TO IFN-alfa IN PATIENTS WITH CHRONIC MYELOCYTIC LEUKEMIA
Vol. 22     N1-2. - C.73.

Lukyanova N.Y., Kulik G.I., Yurchenko O.V., Shatrova K.M., Vorobyova L.I., Svintitsky V.S., Evtushenko G.V., Chekhun V.F.
EXPRESSION OF p53 AND Bcl-2 PROTEINS IN EPITHELIAL OVARIAN CARCINOMA WITH DIFFERENT GRADE OF DIFFERENTIATION
Vol. 22     N1-2. - C.91.

Horsman M.R., Chaplin D.J., Christensen K.L., Overgaard J.
CADRALAZINE: A LESS TOXIC BUT EQUALLY EFFECTIVE ANALOGUE OF HYDRALAZINE IN VIVO
Vol. 22     N1-2. - C.32.

Tanaka Y., Harima Y.
ONCOPROTEIN EXPRESSION PREDICTS RESPONSE TO RADIOTHERAPY OR THERMORADIOTHERAPY IN HUMAN CERVICAL CANCER
Vol. 22     N1-2. - C.52.

Bhujwalla Z.M., Artemov D., Solaiyappan M.
INSIGHTS INTO TUMOR VASCULARIZATION USING MAGNETIC RESONANCE IMAGING AND SPECTROSCOPY
Vol. 22     N1-2. - C.3.

Osinsky S., Shidnia H.
THE 20th ANNIVERSARY OF THE INTERNATIONAL CLINICAL HYPERTHERMIA SOCIETY (ICHS): EXPERIMENTAL AND CLINICAL EXPERIENCE
Vol. 22     N1-2. - C.95.

Vaupel P., Kelleher D.K., Thews O.
MICROTOPOLOGY OF LOCAL PERFUSION, OXYGENATION, METABOLIC AND ENERGETIC STATUS, AND INTERSTITIAL pH IN MALIGNANT TUMORS: TECHNIQUES AND CHARACTERIZATION
Vol. 22     N1-2. - C.15.

Guslitser L.
JOINT MEETING OF NATIONAL ACADEMY OF SCIENCES AND ACADEMY OF MEDICAL SCIENCES OF UKRAINE DEVOTED TO THE CENTENARY OF R.E. KAVETSKY
Vol. 22     N1-2. - C.94.

Smorodin E.P., Kurtenkov O.A., Sergeyev B.L.
THE APPLICATION OF HUMAN NATURAL POLYCLONAL IgG-ANTIBODIES TO THOMSEN-FRIEDENREICH EPITOPE (TFE) FOR EVALUATION OF TFE EXPRESSION IN CANCER-ASSOCIATED MUCINS
Vol. 22     N1-2. - C.44.

Blitvich B.J., Ward B.K., Frost F.A., Ingram D.M., Byme M.J., Ratajczak T.
USE OF FINE-NEEDLE ASPIRATES FOR THE IDENTIFICATION OF MUTATIONS WITHIN THE ESTROGEN RECEPTOR-alfa HORMONE-BINDING DOMAIN IN TAMOXIFEN-RESISTANT HUMAN BREAST CARCINOMAS
Vol. 22     N1-2. - C.38.

Glehen O., Peyrat P., Beaujard A., Caillot J.L., Francois Y., Gueugniaud P.Y., Garbit F., Bienvenu J., Vignal J., Gilly F.-N
ABDOMINAL CANCER WITH PERITONEAL CARCINOMATOSIS TREATED BY PERITONECTOMY PROCEDURE AND INTRAPERITONEAL CHEMOHYPERTHERMIA
Vol. 22     N1-2. - C.59.

Xu Z.-W, Friess H., Buchler M.W.
MOLECULAR BIOLOGY OF PANCREATIC CANCER
Vol. 22     N1-2. - C.8.

Imamura N.
HEMATOLOGICAL DISORDERS INDUCED BY IRRADIATION IN HIROSHIMA AND CHERNOBYL: ANALYSIS OF MYELOPEROXIDASE-NEGATIVE ACUTE LEUKEMIAS BY FLOW CYTOMETRY AND POINT MUTATIONS OF p53 SUPPRESSOR ONCOGENE IN MYELODYSPLASTIC SYNDROME
Vol. 22     N1-2. - C.64.

B_asiak J., Smolarz B., Kubryn I., Kulig A., Dziki A., Ulanska J., Pander B.
PLASMINOGEN ACTIVATOR INHIBITOR-1 (PAI-1) LEVEL AND 4G/5G GENETIC POLYMORPHISM IN PATIENTS WITH COLORECTAL CANCER
Vol. 22     N1-2. - C.48.


Shlyakhov V.A.
MODERN TRENDS IN CANCER VACCINOTHERAPY
Vol. 22     N3. - C.99.

Bratslavska O., Ivanova K., Kozireva S., Kalnberza G., Tomsone V., Murovska M.
MALIGNANT TRANSFORMATION OF HUMAN NON-LYMPHOID CELL LINE INFECTED BY HTLV-I
Vol. 22     N3. - C.110.

Bobrova T.S., Chuev Yu.V, Morozov V.A.
MOUSE MONOCLONAL ANTIBODY TO HELA-ASSOCIATED ANTIGEN: ANTIGEN DISTRIBUTION IN NORMAL AND MALIGNANT TISSUES
Vol. 22     N3. - C.118.

Korchynskyi A., Korchynska E., Stoika R.
TRANSFORMING GROWTH FACTOR b1 PROTECTS HUMAN LUNG ADENOCARCINOMA CELLS FROM HYPERTHERMIA-INDUCED APOPTOSIS
Vol. 22     N3. - C.126.

Phylchenkov A.A., Slukvin I.I., Kudryavets Yu.I
PREFERENTIAL COEXPRESSION OF THE FUNCTIONALLY ACTIVE RECEPTORS FOR EGF AND TRANSFERRIN IN SOME HUMAN TUMOR CELL LINES OF THE EPITHELIAL ORIGIN
Vol. 22     N3. - C.130.

Rodnin N.V., Tykhonkova I.O., Nemazany I.O., Gorlova L.M., Komissarenko I.V., Palchevskiy S.S., Kuharenko O.P., Drobot L.B., Matsuka G.H., Filonenko V.V., Gout I.T.
SEROLOGICAL IDENTIFICATION OF AUTOIMMUNE REACTIVE ANTIGENS IN HUMAN THYROID CANCER CELLS
Vol. 22     N3. - C.135.

Melnikov O.R., Momot V.Ya, Pyatchanina T.V., Sidorik E.P.
CHANGE OF RATIO BETWEEN FERRO- AND FERRICYTOCHROME P-450 IN LIVER IS AN INDISPENSABLE FEATURE OF NDEA-INDUCED TRANSFORMATION OF HEPATOCYTES
Vol. 22     N3. - C.139.

Baykova V.N., Durnov L.A., Chernova N.V., Zaeva G.E., Zaitseva L.A., Dumbrais K.O., Zakharova N.V., Gracheva I.V., Leonidova Yu.A, Lebedev V.I., Moiseenko E.I.
TYROSINE METABOLISM, ANTIOXIDANT STATUS AND SOME PARAMETERS OF FREE-RADICAL LIPID PEROXIDATION IN CHILDREN SUFFERING FROM MELANOMA AND PIGMENTED NEVI
Vol. 22     N3. - C.142.

Surgova T.M., Sidorenko M.V., Galich I.P., Evtushenko N.V.
HETEROGENEITY OF GLYCOPROTEIN FRACTIONS IN BLOOD SERUM OF TUMOR-BEARING ANIMALS
Vol. 22     N3. - C.148.

Ray M.R., Lakshmi C., Deb C., Pal B.
DOPAMINE ACCELERATES RECOVERY FROM CYCLOPHOSPHAMIDE-INDUCED LEUKOPENIA
Vol. 22     N3. - C.153.

Kharkowskaya N.A., Krasnova T.A., Klepikov N.N., Khrustalev S.A.
ONCOLOGIC AND GENETIC CHARACTERISTICS OF A/SN MICE
Vol. 22     N3. - C.157.

Zinchenko V.A., Klyushin D.A., Baraboy V.A., Petunin Yu.I, Ganina K.P., Lavrenchuk G.I., Dudchenko T.M.
MATHEMATICAL ANALYSIS OF MORPHOLOGYCAL ALTERATIONS IN RADIORESISTANT TUMOR CELLS
Vol. 22     N3. - C.160.

Puscas I., Puscas C., Coltau M., Baican M., Domuta G.
THE SERUM OF CARCINOMA PATIENTS POWERFULLY ACTIVATES CARBONIC ANHYDRASE II
Vol. 22     N3. - C.162.

Editorial_board
ONKOLOGY 2000
Vol. 22     N3. - C.165.

Editorial_board
LEONID G. ROSENFELD
Vol. 22     N3. - C.169.

Editorial_board
LUDMILA B. PINCHOUK
Vol. 22     N3. - C.171.

Editorial_board
VOLODYMIR O. LOGYNSKIJ
Vol. 22     N3. - C.172.

Editorial_board
THE 2ND CONGRESS OF ONCOLOGISTS OF THE CIS COUNTRIES WITH PARTICIPATION OF SCIENTISTS FROM EUROPE, AMERICA AND ASIA
Vol. 22     N3. - C.173.

Editorial_board
III CONFERENCE OF YOUNG SCIENTISTS "MODERN PROBLEMS OF EXPERIMENTAL AND CLINICAL ONCOLOGY"
Vol. 22     N3. - C.174.

Khudoley V.V.
THE CARCINOGENS: CHARACTERISTICS AND MECHANISMS OF ACTION
Vol. 22     N3. - C.175.


Sidorik E.P., Burlaka A.P.
MOLECULAR MECHANISMS OF CELL ALTERATIONS CAUSED BY CHRONIC EXPOSURE TO LOW INTENSITY IONIZING RADIATION DUE TO CHERNOBYL ACCIDENT
Vol. 22     N4. - C.179.

Takahashi H., Suda T., Motoyama H., Uzuka T., Takahashi S., Morita K., Kakinuma K., Tanaka R.
RADIOFREQUENCY INTERSTITIAL HYPERTHERMIA OF MALIGNANT BRAIN TUMORS: DEVELOPMENT OF HEATING SYSTEM
Vol. 22     N4. - C.186.

Lenskaya R.V., Kolenkova G.V., Timakov A.M.
CLINICAL VALUE OF CD-ANTIGEN EXPRESSION PATTERNS ON BLAST CELL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Vol. 22     N4. - C.191.

Chekhun V.F., Todor I.N., Solyanik G.I., Kulik G.I., Tryndiak V.P.
OXIDATIVE PHOSPHORYLATION AND ENERGY STATUS IN DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT GUERIN CARCINOMA
Vol. 22     N4. - C.195.

Chudina A.P., Maliaka Yu.K, Kolesnikova T.N.
HEREDITARY AND FAMILIAL COLORECTAL CANCER (CLINICO-GENEALOGICAL STUDY)
Vol. 22     N4. - C.200.

Golenko O.D., Kharchenko M.F., Myasishcheva N.V., Gudkova M.V.
MODIFYING EFFECTS OF HEPARAN SULFATE FROM LEUKEMIC CELLS ON GROWTH OF STROMAL CELLS OF RAT BONE MARROW
Vol. 22     N4. - C.207.

Meniok T.A., Voyejkova I.M., Yudina O.Y., Mosienko V.S., Shynkarenko L.N., Savtsova Z.D.
EFFECT OF IMMUNOMODULATOR FROM LACTOBACILLUS DELBRUECKII ON THERAPEUTIC EFFICACY OF CYCLOPHOSPHAMIDE IN MICE WITH LEWIS CARCINOMA
Vol. 22     N4. - C.211.

Simeonova M., Ivanova T.
TISSUE DISTRIBUTION OF POLYBUTYLCYANOACRYLATE NANOPARTICLES IN EHRLICH ASCITES TUMOR-BEARING MICE
Vol. 22     N4. - C.215.

Arutyunyan R.M., Hovhannisyan G.G., Ghazanchyan E.G., Oganessian N.M., Nersesyan A.K.
UV-C INDUCED DNA DAMAGE IN LEUKOCYTES OF CHERNOBYL ACCIDENT CLEAN-UP WORKERS
Vol. 22     N4. - C.219.

Smirnova Z.S., Kulagina T.F., Osetrova I.P., Khrustalev S.A., Ustinov A.T., Gerasimova G.K.
EVALUATION OF ANTITUMOR EFFICACY OF ESTRAZIN IN RAT PROSTATIC ADENOCARCINOMA
Vol. 22     N4. - C.222.

Gogol S.V., Berdinskikh N.K.
REDUCTION OF DOXORUBYCIN TOXICITY BY CERULOPLASMIN
Vol. 22     N4. - C.225.

PIotnikov M.B., Maslov M.Yu, Aliev O.I., Vasiliev A.S., Tjukavkina N.A.
RHEOLOGICAL STATUS OF RATS UNDER COMBINED ADMINISTRATION OF CYCLOPHOSPHAMIDE AND ANTIOXIDANT COMPLEX
Vol. 22     N4. - C.228.

Soldatkina M.A., Lytvyn D.I., Alistratov A.V., Pogrebnoy P.V.
EFFECTS OF D-PENICILLAMINE ON GROWTH AND METASTASIS OF LEWIS LUNG CARCINOMA
Vol. 22     N4. - C.231.

Grinevich Yu.A, Beres Jr J., Zinchenko V.A., Martynenko S.V.
EFFECT OF TRACE ELEMENT SOLUTION ON RADIOSENSITIVITY OF TRANSPLANTABLE RAT TUMORS
Vol. 22     N4. - C.233.

Nizenkovska I.V., Chekman I.S., Oliynyk S._., Briuzgina T.S., Gorchakova N.A.
INFLUENCE OF NONGLYCOZIDE CARDIOTONIC ON OXIDATIVE HOMEOSTASIS AND FATTY ACID PATTERNS OF LIPIDS IN MYOCARDIUM AND LIVER UNDER CONDITIONS OF DAUNORUBICIN INTOXICATION
Vol. 22     N4. - C.236.

Butenko Z.A., Phylchenkov A.A.
MODERN CONCEPTS OF VIRAL ONCOGENESIS: FUNDUMENTAL AND APPLYIED ASPECTS
Vol. 22     N4. - C.239.

Senko L.N., Zozulja Y.A.
ROLES OF NITRIC OXIDE IN ONCOGENESIS OF GLIOMAS
Vol. 22     N4. - C.246.

Editorial_board
ACADEMICIAN OF NAS AND AMS OF UKRAINE V.G. PINCHUK: 70th ANNIVERSARY
Vol. 22     N4. - C.251.

Komissarenko S.V.
INTERLEUKINS AND CANCER (N.M. BEREZHNAYA, V.F. CHEKHUN)
Vol. 22     N4. - C.253.


Vanden_Eynde J.J., Mayence A.
EN ROUTE TO MACROCYCLIC PYRIDINOPHANES AS ANTICANCER DRUGS. SYNTHETIC WAYS TO THE BUILDING BLOCKS. (Mons, Belgium)
Vol. 22     N5. - C.4.

Kholodovych V., Mogilevich S., Luik A.
COMPUTED-AIDED PREDICTION OF ANTITUMOR ACTIVITY OF CISPLATIN DERIVATIVES USING METHODS OF ARTIFICIAL INTELLIGENCE. (Kiev, Ukraine)
Vol. 22     N5. - C.11.

Kuz'min V.E., Lozitsky V.P., Kamalov G.L., Lozitskaya R.N., Zheltvay A.I., Fedtchouk A.S., Kryzhanovsky D.N., Kovdienko N.A., Vanden_Eynde J.J., Dyachenko N.S., Nosach L.N.
ANALYSIS OF ANTICANCER ACTIVITY OF PYRIDINOPHANES WITHIN THE FRAMEWORK OF "MOLECULAR STRUCTURE - PROPERTIES" DESCRIPTOR-TOPOLOGICAL MODELS.
Vol. 22     N5. - C.16.

Chekhun V., Shishova Yu., Yurchenko O., Vodyanik M., Sidorenko S.
DRUG RESISTANCE IN KB/DDP5 CELLS ASSOCIATED WITH HYPERSENSITIVITY TO CD95-MEDIATED APOPTOSIS. (Kiev, Ukraine)
Vol. 22     N5. - C.20.

Sidorenko S., Yurchenko O., Shlapatska L., Mikhalap S., Berdova A., Yun T.J., Nichols K.E., Clark E.A.
CDW150 IS A SIGNALING MOLECULE THAT MODULATES CD-95-MEDIATED APOPTOSIS. (Kiev, Ukraine; Seattle WA, Philadelphia PA, USA)
Vol. 22     N5. - C.27.

Mikholap S., Shlapatska L., Berdova A., Yurchenko O., Lopez F., Lukyanova N., Sidorenko S.
MONOCLONAL ANTIBODY IPO-38 IN EVALUATION OF PROLIFERATIVE ACTIVITY OF TUMOR CELLS. (Kiev, Ukraine; Bordo, France)
Vol. 22     N5. - C.36.

Osinsky S., Levitin I., Sigan A., Bubnovskaya L., Ganusevich I., Tsikalova M., Zagorujko L.
"INORGANIC" COBALT (III) COMPLEXES WITH SCHIFF BASES AS A NEW ANTICANCER AGENTS WITH RADIO/THERMOSENSITIZING ACTIVITIES. (Kiev, Ukraine; Moscow, Russia)
Vol. 22     N5. - C.39.

Lombardi V.
INTERNATIONAL COOPERATIVE STUDY OF ABERRANT GANGLIOSIDES ASSOCIATED WITH BRAIN GLIOMAS. (Bari, Italy)
Vol. 22     N5. - C.43.

Santamaria L., Bianchi-Santama A., Gobbi M.
ABSORPTION, DISTRIBUTION AND STORAGE OF INTACT BETA-CAROTENE IN RAT ORGANS AND LIVER SUBCELLULAR FRACTIONS. AN OVERVIEW. (Pavia, Italy)
Vol. 22     N5. - C.46.

Sidorik L.
THE PERSPECTIVES FOR USE OF NATURAL AND PROVOCATED ANTIBODIES IN THE INVESTIGATIONS OF STRUCTURAL BASIS OF HUMAN DNA TOPOISOMERASES I AND II FUNCTIONS AND MOLECULAR MECHANISMS OF THEIR POSONING BY ANTITUMOR DRUGS. (Kiev, Ukraine)
Vol. 22     N5. - C.53.


<< to the beginning of the text